These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2692817)

  • 21. National hospital survey of anaerobic culture and susceptibility methods: III.
    Goldstein EJ; Citron DM; Goldman PJ; Goldman RJ
    Anaerobe; 2008 Apr; 14(2):68-72. PubMed ID: 18291689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A; Roudon T
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
    Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility variation of 50 anaerobic periopathogens in aggressive periodontitis: an interindividual variability study.
    Lakhssassi N; Elhajoui N; Lodter JP; Pineill JL; Sixou M
    Oral Microbiol Immunol; 2005 Aug; 20(4):244-52. PubMed ID: 15943770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines.
    Ambler J; Rennie R; Poupard J; Koeth L; Stass H; Endermann R; Choudhri S
    Diagn Microbiol Infect Dis; 2008 May; 61(1):49-57. PubMed ID: 18342475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
    Wexler HM; Engel AE; Glass D; Li C
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4413-7. PubMed ID: 16189137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activity of imipenem and 15 other antimicrobial agents against clinically important aerobic and anaerobic bacteria.
    Goldstein EJ; Citron DM
    Clin Ther; 1988; 10(5):487-515. PubMed ID: 2856592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility of anaerobic bacteria in Bulgaria.
    Marina M; Ivanova M; Kantardjiev T
    Anaerobe; 2009 Aug; 15(4):127-32. PubMed ID: 19292999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organisms isolated from dogs and cats with anaerobic infections and susceptibility to selected antimicrobial agents.
    Jang SS; Breher JE; Dabaco LA; Hirsh DC
    J Am Vet Med Assoc; 1997 Jun; 210(11):1610-4. PubMed ID: 9170087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance and susceptibility testing of anaerobic bacteria.
    Schuetz AN
    Clin Infect Dis; 2014 Sep; 59(5):698-705. PubMed ID: 24867792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversies in susceptibility testing of anaerobes.
    Aldridge KE
    Clin Ther; 1987; 10 Suppl A():2-11. PubMed ID: 3319171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of obligate anaerobic bacterial sensitivity to tinidazole and metronidazole (determination of minimal inhibiting concentration--MIC)].
    Kałowski M; Dybicki J; Kedzia A; Lukiański M
    Wiad Lek; 1993 Mar; 46(5-6):211-5. PubMed ID: 8249400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A survey of the identification and susceptibility testing of anaerobes in diagnostic microbiology laboratories in Scotland, UK.
    Smith AJ; Lockhart DE; Tyers A; Poxton IR
    J Antimicrob Chemother; 2010 Apr; 65(4):805. PubMed ID: 20142266
    [No Abstract]   [Full Text] [Related]  

  • 35. Methods for susceptibility testing of anaerobic bacteria.
    Olsson-Liljequist B; Nord CE
    Clin Infect Dis; 1994 May; 18 Suppl 4():S293-6. PubMed ID: 8086578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility testing of anaerobic bacteria--the state of the art.
    Wexler HM
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S328-33. PubMed ID: 8324142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of methods for susceptibility testing of anaerobes.
    Zabransky RJ
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1025-31. PubMed ID: 1295756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspective on susceptibility testing of anaerobic bacteria.
    Finegold SM
    Clin Infect Dis; 1997 Sep; 25 Suppl 2():S251-3. PubMed ID: 9310696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inoculum preparation for anaerobic susceptibility tests.
    Murray PR; Niles AC
    J Clin Microbiol; 1983 Sep; 18(3):733-4. PubMed ID: 6630450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility testing of anaerobes.
    Wasilauskas BL
    Pediatr Infect Dis J; 1989 Aug; 8(8):538-9. PubMed ID: 2771535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.